Isolation from cannabis sativa L. of cannflavin—a novel inhibitor of prostaglandin production
References (17)
- et al.
Biochem. Pharmac.
(1973) - et al.
Biochem. Pharmac.
(1982) - et al.
Prostaglanclins
(1980) Trans. med. phys. Soc. Calcutta
(1842)- et al.
- et al.
Br. med. Bull.
(1983)- et al.
J. pharm. Pharmac.
(1982)
There are more references available in the full text version of this article.
Cited by (62)
A validated method for detection of cannflavins in hemp extracts
2023, Journal of Pharmaceutical and Biomedical AnalysisInterference of neuronal TrkB signaling by the cannabis-derived flavonoids cannflavins A and B
2023, Phytomedicine PlusCannflavins – From plant to patient: A scoping review
2020, FitoterapiaCitation Excerpt :Cannflavins were first identified in 1980 by Crombie et al. who uniquely isolated CFL-A and CFL-B from Cannabis sativa L. [10]. In a collection of studies published during 1985 and 1986, Barret et al. studied the ability of both compounds to inhibit prostaglandin E2 (PGE2) release from human rheumatoid synovial cells, demonstrating potency 30 times that of aspirin in an ex vivo setting [11,12]. There is an ongoing need for development of novel anti-inflammatory medications in the setting of rising incidence of inflammatory and auto-immune conditions globally [13].
Medicinal cannabis: Pharmaceutical forms and recent analytical methodologies
2020, Comprehensive Analytical Chemistry
Copyright © 1985 Published by Elsevier Inc.